Technical420 Site Search

GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full year 2020 and key priorities for 2021. Justin Gover, GW’s Chief Executive Officer, expects to discuss these updates as…

The cannabis industry made significant strides during 2016 and we think this is just the beginning…Although 2016 was a banner year for the cannabis industry, we expect 2017 to be even more significant. As we approach the end of 2016, we want to take the opportunity to highlight the most…

Agencies across the globe continue to recognize the medical benefits associated with cannabis. It is only a matter of time before this incredible plant will be legalized in the United States.From the National Cancer Institute (NCI) to the National Institute on Drug Abuse (NIDA), the medical benefits associated with cannabis…

This morning, Nasdaq-traded biotech firm GW Pharmaceuticals (GWPH) reported its fourth quarter earnings and the shares are trending higher in pre-market trading.The company also announced additional positive Epidiolex Phase 3 data in poster presentations at the 70th Annual Meeting of the American Epilepsy Society. The studies represented in the posters…

GW Pharmaceuticals plc (GWPH) continues to lead the medical cannabis movement…This morning, the company reported its second positive Stage 3 Clinical trial for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).This trial follows the announcement in June 2016 of positive results in the first pivotal…

GW Pharmaceuticals (GWPH) shares jumped more than 20% after it reported that it was working with Morgan Stanley after other drug makers approached it to express interest in an acquisition, according to people familiar with the matter.GW is one of the leaders in the cannabis industry. The British biopharmaceutical company…

The state of the global economy has led to a number of the best investors and economists to predict a recession within the next 12 to 18 months.As market volatility continues to increase, investors and money managers will continue to exit the stock market as they look for new investment…

GW Pharmaceuticals plc (GWPH) has once again changed the landscape of the cannabis industry as the company reported its second positive Stage 3 Clinical trial for its Epidiolex product.The results for this trial were for the treatment of Lennox-Gastaut syndrome (LGS) and Epidiolex was able to significantly reduce the number…

In a letter to senators, the Drug Enforcement Administration said that they plan to decide whether marijuana should be reclassified under federal law in the first half of 2016.The letter was sent in response to a letter from Democratic Senator Elizabeth Warren (Massachusetts) and sever other Democratic Senators in 2015.…

The termination of the $160 billion merger between Pfizer Inc. (PFE) and Allergan Plc (AGN) has been confirmed.The driving factor behind this decision stems from the rules issued by the United States Treasury Department which are focused on making tax inversion deals less profitable.Moving Addresses, Not AssetsPresident Obama said the…